Taisho Pharmaceutical Holdings Co., Ltd.
TAIPY · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,873 | $3,087 | $4,363 | -$1,902 |
| Dep. & Amort. | $0 | $7,289 | $6,952 | $6,716 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $0 | $0 | $0 | $0 |
| Other Non-Cash | -$2,873 | -$3,087 | -$4,363 | $1,902 |
| Operating Cash Flow | $21,194 | $14,578 | $13,904 | $13,432 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $0 | -$32,715 | $16,115 | -$33,115 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $215,474 | $248,189 | $232,074 | $265,189 |
| End Cash | $246,071 | $215,474 | $248,189 | $232,074 |
| Free Cash Flow | $21,194 | $14,578 | $13,904 | $13,432 |